Table 2.
Captured mAb | Second mAb, response units |
||||||
---|---|---|---|---|---|---|---|
20 | 109 | 49 | 51 | 53 | 116 | MOPC21 | |
Group I | |||||||
49 | 69.3 | 71.2 | 17.5 | 13.7 | 13.7 | 57.1 | 17 |
51 | 68.8 | 70.3 | 14.5 | 12.8 | 14.3 | 54.8 | 18.6 |
53 | 67.4 | 68.4 | 16.1 | 14.5 | 14.3 | 53.7 | 18.5 |
Group II | |||||||
20 | 9.7 | 15.4 | 43 | 41.4 | 40 | 72.1 | 7.7 |
109 | 26 | 25.1 | 62.1 | 60.7 | 61.1 | 100.4 | 17.2 |
Group III | |||||||
116 | 86.3 | 89.9 | 60.8 | 59.7 | 59.2 | 13.4 | 19.3 |
Control | |||||||
MOPC21 | 26.5 | 30 | 21.5 | 19.7 | 20.2 | 16.7 | 20.1 |
Pairwise epitope mapping was performed and compared with the isotype control, MOPC21, as described in “Pairwise epitope mapping.” Results are representative of three profiling experiments.